Abstract Introduction Pre‐exposure prophylaxis (PrEP) is an important HIV prevention
option. Two randomized trials have provided efficacy evidence for long‐acting injectable …

Introduction Strategies of harm reduction (HR) include policies and community-based
measures aimed to reduce the risk of self-harm while continuing potentially hazardous …

Diagnoses of HIV among people who inject drugs have increased in the US during 2014–
2018 for the first time in 2 decades, and multiple HIV outbreaks have been detected among …

In this guideline, WHO recommends that long-acting injectable cabotegravir (CAB-LA) may
be offered as an additional HIV prevention option for people at substantial risk of HIV …

Pre-exposure prophylaxis (PrEP) is a promising but underutilized HIV prevention tool among
people who inject drugs (PWID). We developed and piloted an intervention to bolster PrEP …

Background Outbreaks of new HIV transmission among people who inject drugs (PWID) are
a major public health concern. Oral daily PrEP, has been identified as a critical addition to …

Background HIV incidence has recently increased among people who inject drugs (PWID)
across the United States, with outbreaks occurring in states with long-standing syringe …

Introduction To realise the expected gains from prevention of mother-to-child HIV
transmission initiatives, adherence to preventative and therapeutic antiretroviral regimens is …

To assess advanced practitioners' scope of practice laws (ie, legal authority providers can
prescribe regulated medications) as potential barriers to HIV pre-exposure prophylaxis …

Background There is an ongoing HIV outbreak amongst people who inject drugs (PWID) in
Glasgow, Scotland, and one response which has not yet been widely implemented is the …